台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    66.6
  • 漲跌
    ▼0.9
  • 漲幅
    -1.33%
  • 成交量
    208
  • 產業
    上櫃 生技醫療類股
  • 71人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-元大-台中 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/2004/0104/0355606570758085May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

元大-台中 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/02266.3000.0066.6025050.40%
2025/03/2700.00173.8073.60-1573-0.17%
2025/03/1900.00273.1572.60-2598-0.33%
2025/03/18578.00075.7075.5056020.83%
2025/03/14277.6500.0077.7026170.32%
2025/03/13380.1700.0081.0036030.50%
2025/03/1200.00180.3077.50-1585-0.17%
2025/03/11177.0000.0081.5015570.18%
2025/03/05069.3000.0068.9004840.00%
2025/03/040.168.9800.0069.600.14830.01%
2025/03/0300.00169.0069.60-1483-0.21%
2024/12/26366.6000.0066.6036920.43%
2024/12/25274.65277.0574.0006830.00%
2024/12/24273.0000.0073.0026770.30%
2024/12/19164.00366.0062.70-2695-0.29%
2024/12/06364.3000.0064.3036510.46%
2024/11/2600.00071.0068.6006810.00%
2024/11/18166.2000.0067.0016760.15%
2024/11/15468.4000.0066.0046780.59%
2024/10/28195.5000.0095.5016880.15%
2024/10/1800.001114.00110.00-1768-0.13%
2024/10/170.5119.0000.00122.000.57790.06%
2024/10/161117.0000.00117.0017990.13%
2024/10/1100.000.5114.50114.50-0.5824-0.06%
2024/10/040.5101.2400.00106.500.58130.06%
2024/09/2400.000.1167.70159.00-0.1789-0.01%
2024/09/230157.0000.00158.0007940.00%
2024/09/200.1172.500174.00169.0007820.01%
2024/09/1100.000188.45185.000792-0.01%
2024/09/0900.001191.00195.00-1808-0.12%
2024/09/0600.003193.50195.00-3800-0.37%
2024/08/303227.0000.00216.0037920.38%
2024/08/280211.0000.00210.0007880.00%
2024/08/261225.500228.00226.0017900.13%
2024/08/2300.001227.00229.00-1798-0.13%
2024/08/221227.0000.00221.5017980.13%
2024/08/210224.5000.00225.0008020.00%
2024/08/1500.0010191.70191.50-10827-1.21%
2024/08/130190.0000.00189.0008430.00%
2024/08/1200.001203.50198.00-1835-0.12%
2024/08/0910205.501.1204.09203.508.98241.08%
2024/08/0800.000.4185.50187.00-0.4794-0.05%
2024/08/050.1178.8600.00180.000.17680.01%
2024/07/2300.000164.21160.0006850.00%
2024/07/220166.0000.00164.0006670.00%
2024/07/1900.001183.50182.00-1650-0.15%
2024/07/1800.001190.00196.50-1611-0.16%
2024/07/172180.7500.00191.0025890.34%
2024/07/1500.001161.00164.50-1554-0.18%
2024/07/1100.000.2149.00149.00-0.2531-0.03%
2024/07/0800.000131.00138.5004930.00%
2024/07/0500.001129.00127.50-1480-0.21%
2024/07/040124.5000.00126.0004770.00%
2024/07/0100.001134.00137.50-1435-0.23%
2024/06/281130.0000.00130.0014130.24%
2024/06/270.2114.002118.25118.50-1.8393-0.46%
2024/06/2600.002101.50108.00-2378-0.53%
2024/06/2500.000103.00101.5003730.00%
2024/06/19199.9000.00101.5013740.27%
2024/06/1700.001105.00108.00-1353-0.28%
2024/06/12198.5000.0097.4013270.31%
2024/06/111100.5000.00101.5013240.31%
2024/05/23197.970.496.62100.500.62860.21%
2024/05/2200.00192.6091.50-1260-0.38%
2024/05/21191.2000.0093.0012500.40%
2024/05/202.482.9100.0086.302.42381.01%
2024/04/30169.3000.0071.3012580.39%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音
 
 
05小時41